- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT00846534
The Assessment of Oxidative Stress Markers and the Development of Atrial Fibrillation After Cardiac Surgery (POAF)
Studienübersicht
Status
Bedingungen
Detaillierte Beschreibung
Atrial Fibrillation (AF) is a common occurrence after cardiac surgery. This arrhythmia is reported to occur in up to 40% of patients following coronary bypass graft (CABG) surgery. The incidence of AF is even higher in patients who have undergone both CABG and valvular surgery during the same operation. In cardiac surgery patients, the occurrence of atrial fibrillation post-operatively lengthens hospitalization and adds to postoperative complications like renal dysfunction, infection, and cognitive defects. Postoperative AF is a known major risk factor for the development of stroke after cardiac surgery. Additionally, there is data to suggest that the development of AF after cardiac surgery is related to both reduced survival after CABG, and this dysrhythmia may also serve as an independent predictor of long-term mortality. Many studies have investigated the role of prophylactic pharmacological therapy to prevent post-operative AF after cardiac surgery. Despite this, the complete pathogenesis of AF in the post-cardiac surgery population remains unknown, is likely to be multifactorial, and includes clinical, structural, and biochemical risk factors.
Biochemical risk factors such as inflammation and elevated markers of oxidative stress seem to be related to the development of AF. Also, It has been shown that AF is associated with decreased activity of nitric oxide synthases. Elevated C-reactive protein (CRP), a common marker of inflammation, has been shown to be associated with chronic AF at one year follow up. Additionally, elevated CRP levels drawn just prior to electrical cardioversion have been found to predict the development of recurrent AF after cardioversion. This relationship between this elevated marker of inflammation - CRP - and AF has been found to be independent of clinical risk factors for the development of AF, such as age, diabetes, and left ventricular function. Inflammation is a known source of oxidative stress at the cellular level; and it has been proposed that both inflammation and oxidative stress play a role in electrical remodeling of the atria, which promotes perpetuation of AF. Moreover, it has been proposed that CRP levels may directly reflect the condition of increased oxidative stress.
Oxidative Stress and Arrhythmia:
The association between AF and arrhythmias has been suggested by an array of evidence. Moreover, the pathogenesis likely involves both changes in the atrial architecture, such as dilation and fibrosis, and alterations in the electrophysiological substrate of atrial tissue. Oxidative stress markers are believed to be involved in remodeling of the atrial electrophysiological substrate.
Recently, a correlation between AF and oxidative stress markers has been established. In one study, a correlation between the oxidative stress markers reduced glutathione, cysteine, and derivatives of reduced oxidative metabolites has been found. Although the relationship between AF and oxidative stress remains unclear, it is known from this human population study that oxidative stress markers are elevated in those with persistent AF. This relationship holds true even after controlling for conditions that promote oxidative stress: hypertension, smoking, and congestive heart failure. It has also been shown that atrial tachycardias are associated with increased hydroxyl radicals and peroxynitrite. These species are believed to cause myofibril damage and reduced myofibrillar creatine kinase activity in those with chronic AF. Similarly, superoxide free radicals were shown to be elevated in the porcine heart left atrial appendage when subjected to rapid atrial pacing and AF. Of further interest in this study by Dudley et al., was the role of an NADPH oxidase inhibitor, apocynin, in its ability to reduce superoxide production. This suggests that the NADPH oxidase plays a prominent role in the development of reactive oxidative species. In turn, such reactive oxidative species are thought to be related to inflammation and atrial electrical remodeling.
It is believed that electrical remodeling leads to changes such as shortening of the effective refractory period (ERP), loss of rate adaptation of the refractory period, and prolonged atrial conduction. Rapid atrial conduction likely results in increased calcium (Ca2+) accumulation. This causes decreased inward L-type Ca2+ current (ICa), resulting in a shorter action potential duration (APD). Additional cellular mechanisms may include inactivation of the fast sodium current (INa) at more positive membrane potentials, and increased inward potassium rectifier (IK1) and acetylcholine dependent potassium currents (IKAch). Though these currents logically oppose one another, the net effect is that of increased repolarization heterogenicity and shortened APD. Moreover, experimental models have shown that rapid atrial pacing leads to decreased ERP and reduced of L-type Ca2+ channel and transient outward K+ ion currents. Shortening of the ERP leads to decreased conduction wavelengths, and shortened wavelengths have been proposed to increase the propensity for the development of AF because they reduce the mass of atrial tissue required to sustain reentry circuits.
Given the changes above, it has been postulated that intracellular calcium overload as a result of AF is a trigger for electrical remodeling in AF. Nevertheless, further studies have demonstrated that blockade of L-type calcium channels alone with verapamil in canine hearts is not sufficient to prevent atrial electrical remodeling. Additional triggering mechanisms may include oxidative stress and inflammation. Simvastatin, a drug that has both anti-oxidant and anti-inflammatory properties has been shown to attenuate the development of AF from tachycardia induced atrial remodeling in dogs. More specific evidence of ion channel remodeling from free radicals was proved by Caouette et al. who showed that addition of hydrogen peroxide directly delayed ultra-rapid rectifier potassium currents in the Chinese Hamster Ovary cell line. These changes are mediated by Kv1.5 gene expression, which accounts for voltage-gated potassium repolarization currents that are similarly expressed in human atrial and ventricular myocytes. Further ion channel studies have demonstrated that lipid peroxidation causes Na+ channel dysfunction in cultured atrial myocytes when exposed to the oxidizing agent tert-butyl-hydroperoxide . Additionally, it is believed that reactive oxidative species may promote respiratory chain dysfunction in atrial myocytes by way of mitochondrial DNA damage.
In summary, the relationship between oxidative stress and atrial fibrillation is complex and incompletely understood on the molecular level. Nevertheless, it is clear that this relationship does exist, and therefore serves as a potential focus for medical therapy. In fact, Carnes et al. clearly demonstrated that using ascorbate perioperatively to blunt the effects of oxidative stress results in both decreased peroxynitrite formation and a lower incidence of AF after CABG. Therefore, investigators propose to do more work in this arena to better elucidate the relationship of oxidative stress and AF.
Oxidative Stress Markers in the Research Setting:
Cardiac surgery leads to high oxidative stress and inflammation and is associated with postoperative AF. This is the ideal situation in which to better define oxidative stress markers and their correlation with AF. There are several ways to measure oxidative stress in humans. A minimally invasive method is the measurement of lipid peroxides (derivatives of reactive oxygen metabolites, dROMs) and oxidized and reduced thiol ratios. Glutathione is an important water-phase antioxidant and essential cofactor for antioxidant enzymes. It provides protection endogenous oxygen radicals. Since glutathione can exist in oxidized and reduced forms, it can serve as a buffer for increased oxidative stress. Moreover, the relative amounts of these two forms are a reflection of the oxidative state of humans. This balance can be measured out of blood. Measurement of this ratio has been validated by Neuman et al. and is known to be associated with AF. Additionally, these measurements have been validated in states that are thought to increase oxidative stress, such as diabetes, older age, and cigarette smoking.
Studientyp
Einschreibung (Voraussichtlich)
Kontakte und Standorte
Studienorte
-
-
Illinois
-
Chicago, Illinois, Vereinigte Staaten, 60612
- University of Illinois at Chicago
-
Oak Lawn, Illinois, Vereinigte Staaten, 60453
- Advocate Christ Medical Center
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Probenahmeverfahren
Studienpopulation
Beschreibung
Inclusion Criteria:
- Age ≥18 years
- Sinus rhythm at the time of enrollment as documented by ECG, telemetry, or Holter monitoring
- Scheduled for an open heart surgery
- Able to provide informed consent
Exclusion Criteria:
- Systemic inflammatory diseases (e.g., collagen vascular diseases, infections)
- Malignant neoplasms
- Hyperthyroidism
- Uncontrolled hypertension (blood pressure > 180/100 at rest) on medications
- An illness that might result in death within 1 year
- Implanted devices for designed for active management of atrial arrhythmias by pacing or defibrillation
- Current illicit drug use
- Current ethanol abuse
- Presence of paroxysmal, persistent, or permanent atrial fibrillation at the time of enrollment
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
Kohorten und Interventionen
Gruppe / Kohorte |
---|
Post operative atrial fibrillation
To evaluate the ability of oxidative stress markers to predict postoperative atrial fibrillation in subjects undergoing cardiac surgery.
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Zeitfenster |
---|---|
Baseline of oxidative stress markers prior to subjects undergoing cardiac surgery
Zeitfenster: up to 24 hours pre-op
|
up to 24 hours pre-op
|
To evaluate the ability of oxidative stress markers to predict postoperative atrial fibrillation in subjects undergoing cardiac surgery
Zeitfenster: Day 1 post-op
|
Day 1 post-op
|
To evaluate the ability of oxidative stress markers to predict postoperative atrial fibrillation in subjects undergoing cardiac surgery
Zeitfenster: When develop Atrial Fibrillation or upon discharge from hospital, usually within 1 week post-op
|
When develop Atrial Fibrillation or upon discharge from hospital, usually within 1 week post-op
|
Mitarbeiter und Ermittler
Ermittler
- Hauptermittler: Samuel C Dudley, MD. PhD, University of Illinois at Chicago
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn
Primärer Abschluss (Tatsächlich)
Studienabschluss (Tatsächlich)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Schätzen)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Schätzen)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
- 2007-0916
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .
Klinische Studien zur Vorhofflimmern
-
IRCCS Policlinico S. MatteoUniversity of Pavia; Azienda Regionale Emergenza Urgenza (AREU)RekrutierungAußerklinischer Herzstillstand | Ventrikuläre Fibrillation anhaltendItalien
-
Aurora Health CareRekrutierungVorhofflimmern | Tachykardie atrial | Vorhofflattern mit schneller ventrikulärer ReaktionVereinigte Staaten
-
Biotronik SE & Co. KGAbgeschlossenVorhofflimmern | Bradykardie | Synkope | Kryptogener Schlaganfall | Tachykardie atrialItalien
-
Edgar JaeggiLabatt Family Heart CentreRekrutierungVorhofflattern | Tachykardie, supraventrikulär | Tachykardie, AV-Knoten-Wiedereintritt | Tachykardie atrial | Tachykardie, reziprok | Tachykardie, paroxysmal | Fetaler Hydrops | Tachykardie, atriale EktopieVereinigte Staaten, Hongkong, Kanada, Niederlande, Schweden, Australien, Brasilien, Finnland, Frankreich, Russische Föderation, Spanien, Tschechien, Schweiz, Vereinigtes Königreich